Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medmix AGCHIX:MEDXZ +1.97%66 FCF Margin % is 5.55% as of Jun. 2026, which is 20% below its 10-year median of 6.92. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 66/100 and a GF Value™ of CHF9.05 (Fairly Valued). The stock has 6 warning signs investors should review. Among 3,039 Industrial Products companies, Medmix AG ranks better than 67.82% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medmix AG's Free Cash Flow for the
six
months ended in Jun. 2026 was CHF11.9 Mil. Medmix AG's Revenue for the
six
months ended in Jun. 2026 was CHF214.4 Mil. Therefore, Medmix AG's FCF Margin % for the quarter that ended in Jun. 2026 was 5.55%.
The historical data trend for Medmix AG's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:MEDXZ vs GEV, ETN, PH: FCF Margin % Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG FCF Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medmix AG's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (CHIX:MEDXZ) has a FCF Margin % of 5.55% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medmix AG and its competitors. This is 20% below median its historical median of 6.92. Over the past decade, Medmix AG's FCF Margin % has ranged from 0.66 to 14.14. According to the industry distribution chart, Medmix AG ranks #978 out of 3039 companies in the Industrial Products industry, placing it in the top 32.2%.
Is Medmix AG's FCF Margin % too high?
Medmix AG's current FCF Margin % of 5.55% is 20% below median its 10-year median of 6.92. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 14.14. The Industrial Products industry median FCF Margin % is 1.51. Medmix AG's value of 5.55% is 267.5% above this industry median. Based on the distribution chart, Medmix AG ranks #978 out of 3039 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's FCF Margin % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #978 out of 3039 companies for FCF Margin %. This puts Medmix AG in the upper half of its industry. The industry median FCF Margin % is 1.51. Medmix AG's value of 5.55% is 267.5% above this benchmark. Historically, Medmix AG's own FCF Margin % has ranged from 0.66 to 14.14 over the past decade. While the company's 10-year median is 6.92 vs. the industry median of 1.51, Medmix AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for an Industrial Products company?
The median FCF Margin % among Industrial Products companies is 1.51, based on 3,039 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current FCF Margin % of 5.55% is 267.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median FCF Margin % is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current FCF Margin % is 5.55%, which is 20% below median its own 10-year median of 6.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current FCF Margin % is 5.55%, which is 20% below median its 10-year median of 6.92 and 267.5% above the Industrial Products industry median of 1.51. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current FCF Margin % is 5.55% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05.
GuruFocus considers Medmix AG to be Fairly Valued.
Key valuation signals for CHIX:MEDXZ:
FCF Margin %: 5.55% (20% below median its 10-year median of 6.92)
GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
Industry Position: 267.5% above the Industrial Products median (#978 of 3039)
No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score
Get the complete analysis for CHIX:MEDXZ
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MEDXZ has been successfully added to your 
